Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-14-085538
Filing Date
2014-12-09
Accepted
2014-12-09 08:38:11
Documents
1
Period of Report
2014-12-06

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3850
  Complete submission text file 0001104659-14-085538.txt   5288
Mailing Address
Business Address
JACOB GARY S (Reporting) CIK: 0001266802 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35268 | Film No.: 141273888

Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations